135 related articles for article (PubMed ID: 19820366)
1. DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma.
Karihtala P; Soini Y; Vaskivuo L; Bloigu R; Puistola U
Int J Gynecol Cancer; 2009 Aug; 19(6):1047-51. PubMed ID: 19820366
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis.
Pylväs M; Puistola U; Kauppila S; Soini Y; Karihtala P
Eur J Cancer; 2010 Jun; 46(9):1661-7. PubMed ID: 20206498
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.
Bur H; Haapasaari KM; Turpeenniemi-Hujanen T; Kuittinen O; Auvinen P; Marin K; Koivunen P; Sormunen R; Soini Y; Karihtala P
Histopathology; 2014 Sep; 65(3):319-27. PubMed ID: 24698430
[TBL] [Abstract][Full Text] [Related]
4. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
[TBL] [Abstract][Full Text] [Related]
5. Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
Aman M; Ohishi Y; Imamura H; Shinozaki T; Yasutake N; Kato K; Oda Y
Hum Pathol; 2017 Jun; 64():156-163. PubMed ID: 28438620
[TBL] [Abstract][Full Text] [Related]
6. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.
Sopel M; Surowiak P; Berdowska I
Folia Morphol (Warsz); 2010 Nov; 69(4):204-12. PubMed ID: 21120806
[TBL] [Abstract][Full Text] [Related]
7. Nuclear survivin is associated with malignant potential in epithelial ovarian carcinoma.
Qian X; Xi X; Li L
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):126-32. PubMed ID: 20724919
[TBL] [Abstract][Full Text] [Related]
8. Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma.
Labiche A; Heutte N; Herlin P; Chasle J; Gauduchon P; Elie N
Int J Gynecol Cancer; 2010 Jan; 20(1):28-33. PubMed ID: 20130500
[TBL] [Abstract][Full Text] [Related]
9. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions.
Bock AJ; Stavnes HT; Kempf T; Tropè CG; Berner A; Davidson B; Staff AC
Int J Gynecol Cancer; 2010 Dec; 20(9):1448-55. PubMed ID: 21336029
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
12. Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis.
Karihtala P; Kauppila S; Puistola U; Jukkola-Vuorinen A
Histopathology; 2011 May; 58(6):854-62. PubMed ID: 21585424
[TBL] [Abstract][Full Text] [Related]
13. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas.
Pasanen AK; Kuitunen H; Haapasaari KM; Karihtala P; Kyllönen H; Soini Y; Turpeenniemi-Hujanen T; Kuittinen O
Leuk Lymphoma; 2012 Apr; 53(4):624-31. PubMed ID: 21929285
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
16. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
Isohookana J; Haapasaari KM; Soini Y; Karihtala P
Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
[TBL] [Abstract][Full Text] [Related]
17. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
18. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
Davidson B; Trope' CG; Wang TL; Shih IeM
Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
[TBL] [Abstract][Full Text] [Related]
19. Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma.
Sasaki N; Kudoh K; Kita T; Tsuda H; Furuya K; Kikuchi Y
J Obstet Gynaecol Res; 2007 Feb; 33(1):17-23. PubMed ID: 17212661
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of GRP78 is associated with malignant transformation in epithelial ovarian tumors.
Huang LW; Lin CY; Lee CC; Liu TZ; Jeng CJ
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):381-5. PubMed ID: 22495374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
